Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy
about
Radiotherapy dose-volume effects on salivary gland functionComparison of treatment techniques for reduction in the submandibular gland dose: A retrospective studySubmandibular gland sparing in intensity-modulated radiotherapy for N0-stage nasopharyngeal carcinoma.Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.Sensitivity of salivary glands to radiation: from animal models to therapiesDevelopment and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancerInsulin-like growth factor-1 preserves salivary gland function after fractionated radiationClinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.Early clinical experience with volumetric modulated arc therapy in head and neck cancer patientsIntegrated multicriterial optimization of beam angles and intensity profiles for coplanar and noncoplanar head and neck IMRT and implications for VMAT.Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.Impact of Radiotherapy Dose on Dentition Breakdown in Head and Neck Cancer Patients.Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysisCan knowledge-based DVH predictions be used for automated, individualized quality assurance of radiotherapy treatment plans?A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivoComparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiationSalivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control.Radiation-induced salivary gland dysfunction results from p53-dependent apoptosis.Failure-probability driven dose paintingIMRT for head and neck cancer: reducing xerostomia and dysphagia.Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.Controversies and challenges in the current management of nasopharyngeal cancer.Organ-sparing radiation therapy for head and neck cancer.Salivary gland sparing in the treatment of head and neck cancer.Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.Prospective investigation and literature review of tolerance dose on salivary glands using quantitative salivary gland scintigraphy in the intensity-modulated radiotherapy era.Questionable Necessity for Removing Submandibular Gland in Neck Dissection in Squamous Cell Carcinoma of Oral Cavity.Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study.Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy.Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.Normal tissue anatomy for oropharyngeal cancer: contouring variability and its impact on optimization.Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.IMRT: preliminary results in a series of advanced head-and-neck cancer patients.Consequences of tumor planning target volume reduction in treatment of T2-T4 laryngeal cancer.Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
P2860
Q33698809-2B021579-90F1-48E1-9D83-8AC04B09DAC3Q33753727-C585CFE8-CC9C-4783-984D-5C27A77F208EQ33792266-D71D1702-775B-45B3-B84B-B4F4119EFA0AQ33900763-A4E6020E-EC41-442E-AD23-AF00E3BEF668Q33901931-C9659BF9-8F88-4D6C-BE95-8481A779A4DAQ34118122-0FD70DA5-A2D8-482E-BEB4-0D3D4E258021Q34126820-AFF54ACA-16E5-44F1-9EE3-59416BFC7D0AQ34242059-A1E1FC92-4CDB-484F-A692-2738C89A9B3BQ34283052-625A5BCE-EFAE-4CDE-A103-6C2A0CA26BF3Q34380405-1EDD63CC-B95B-4A5A-9E82-B2ABC3E487EBQ34676530-916A0D5F-5060-427B-891C-8EA1BD8D9F8FQ35165634-E80DB8EE-B58F-4902-BE4A-8B4888849170Q35809636-A6881893-D580-4575-B7A9-B8CA5B0D7144Q35846257-8CBA4138-9A85-4488-9F66-C741B3C0371BQ36530360-FD63019A-C2B1-4086-BD6B-B63433CAEB04Q36581729-AA3FB41C-3FD9-4851-9E41-45950CAC0E5BQ36922981-14057D48-F909-4672-90EE-8DE1B102CB51Q37074063-E2E7AE97-D1F8-4A35-B2F2-F744C3A581D2Q37100018-D1A1DCC7-B487-4BC5-8E70-A70DA4C7D3BBQ37187245-B899D96F-014F-4B85-88B2-0D6FFC852418Q37248648-BC76081B-DCCB-45CC-9789-F71EB1A1DA10Q37333035-AF956C19-E23D-403D-8CAA-E510DCDED715Q37686456-5F819770-B1BC-4EDB-8381-EA5BB0E5DE81Q37711059-ABE8B56D-4EEF-4E4F-B269-4266BEC2CC1FQ37718044-E5D51E29-0F7B-48DF-B92B-0D289AC806C8Q37788242-D0A3421B-2D71-4EAE-80CD-0981521833E8Q37905536-9C2AB5E3-C40C-4A19-80EC-2865A658AFCEQ37934975-57400FD3-E98F-4BB8-866C-B717B104D286Q38284473-5DC0B305-3EEE-4F88-B730-620B05FF8DAEQ38733003-6867BE06-6E47-4DBE-8C3C-9800C9817C2BQ38832745-FA5FE146-95FD-4D2C-B813-31334595CDD2Q39633678-933AF578-84F8-47ED-ABEA-42BBAF12F0D2Q39738530-80C7B314-1680-4A67-8E9C-ECEAB28682F1Q40015181-9D532E9B-3B5D-4CFD-9077-97179F307298Q41451059-43031BFC-FAAF-4639-A288-87A267D5F7A0Q41832088-DBA01035-24BC-4C48-8318-442819947CB2Q41897016-EFAE786C-0D88-4B74-8A52-A7B50F7398F2Q42510603-9421EB07-935B-41A1-8745-39D0569A5F85Q42551787-750D6098-65FB-4BE9-9A82-7AA74DCA8BEDQ42632312-4838EC1C-2E78-4BB8-85DC-26941ECC61B9
P2860
Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Dose-effect relationships for ...... tensity modulated radiotherapy
@en
Dose-effect relationships for ...... tensity modulated radiotherapy
@nl
type
label
Dose-effect relationships for ...... tensity modulated radiotherapy
@en
Dose-effect relationships for ...... tensity modulated radiotherapy
@nl
prefLabel
Dose-effect relationships for ...... tensity modulated radiotherapy
@en
Dose-effect relationships for ...... tensity modulated radiotherapy
@nl
P2093
P2860
P1476
Dose-effect relationships for ...... tensity modulated radiotherapy
@en
P2093
Carol-Anne Murdoch-Kinch
Hyugnjin M Kim
Jonathan A Ship
Karen A Vineberg
P2860
P304
P356
10.1016/J.IJROBP.2007.12.033
P407
P577
2008-03-11T00:00:00Z